New Journal Website is available at:

Published by: Kowsar

Insulin Resistance in Pulmonary Arterial Hypertension, Is It a Novel Disease Modifier?

Nasim Naderi 1 , Pedram Boobejame 1 , Hooman Bakhshandeh 1 , * , Ahmad Amin 1 , Sepideh Taghavi 1 and Majid Maleki 1
Authors Information
1 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: September 2014, 3 (3); e19710
  • Published Online: August 17, 2014
  • Article Type: Research Article
  • Received: April 25, 2014
  • Revised: June 29, 2014
  • Accepted: July 16, 2014
  • DOI: 10.5812/cardiovascmed.19710

To Cite: Naderi N, Boobejame P, Bakhshandeh H, Amin A, Taghavi S, et al. Insulin Resistance in Pulmonary Arterial Hypertension, Is It a Novel Disease Modifier?, Res Cardiovasc Med. 2014 ;3(3):e19710. doi: 10.5812/cardiovascmed.19710.

Copyright: Copyright © 2014, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; 30(20): 2493-537[DOI][PubMed]
  • 2. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, et al. Insulin resistance in pulmonary arterial hypertension. Eur Respir J. 2009; 33(2): 318-24[DOI][PubMed]
  • 3. Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J Heart Lung Transplant. 2011; 30(8): 904-11[DOI][PubMed]
  • 4. Lopez-Lopez JG, Moral-Sanz J, Frazziano G, Gomez-Villalobos MJ, Flores-Hernandez J, Monjaraz E, et al. Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol. 2008; 295(5)-32[DOI][PubMed]
  • 5. Moral-Sanz J, Menendez C, Moreno L, Moreno E, Cogolludo A, Perez-Vizcaino F. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats. Respir Res. 2011; 12: 51[DOI][PubMed]
  • 6. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 Suppl 1-60[DOI][PubMed]
  • 7. Alegria E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, et al. Prevalence of Metabolic Syndrome in the Spanish Working Population: MESYAS Registry. Rev Esp Cardiol (Engl Ed). 2005; 58(7): 797-806[DOI][PubMed]
  • 8. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009; 19(6): 401-8[DOI][PubMed]
  • 9. Murguia-Romero M, Jimenez-Flores JR, Sigrist-Flores SC, Espinoza-Camacho MA, Jimenez-Morales M, Pina E, et al. Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 2013; 54(10): 2795-9[DOI][PubMed]
  • 10. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132(8): 919-23[PubMed]
  • 11. Mostafa SA, Davies MJ, Morris DH, Yates T, Srinivasan BT, Webb D, et al. The association of the triglyceride-to-HDL cholesterol ratio with insulin resistance in White European and South Asian men and women. PLoS One. 2012; 7(12)[DOI][PubMed]
  • 12. Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, March CE, Balbin E, et al. Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance. Diab Vasc Dis Res. 2013; 10(4): 346-52[DOI][PubMed]
  • 13. Movahed MR, Hashemzadeh M, Jamal MM. The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest. 2005; 128(5): 3568-71[DOI][PubMed]
  • 14. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008; 31(1): 96-8[DOI][PubMed]
  • 15. Yan Z, Liu Y, Huang H. Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients. Asian Pac J Trop Med. 2012; 5(6): 469-71[DOI][PubMed]
  • 16. Niranjan G, Arun MS, Srinivasan AR, Muthurangan G, Saha S, Ramasamy R. Association of Levels of Hba1c with Triglyceride/High Density Lipoprotein Ratio–an Indicator of Low Density Lipoprotein Particle Size in Type 2 Diabetes Mellitus. Med Int. 2012; 2(3): 87-95
  • 17. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007; 115(10): 1275-84[DOI][PubMed]
  • 18. West J, Niswender KD, Johnson JA, Pugh ME, Gleaves L, Fessel JP, et al. A potential role for insulin resistance in experimental pulmonary hypertension. Eur Respir J. 2013; 41(4): 861-71[DOI][PubMed]
  • 19. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006; 114(14): 1482-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader